Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 6, 2003, Pages 648-652

  Karacorlu, Murat ^a   Ozdemir, Hakan ^a   Karacorlu, Serra ^a  

^a Istanbul Retina Institute Inc   (Turkey)

Author keywords

Cystoid macular oedema; Intravitreal; Pseudophakia; Triamcinolone acetonide

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE IODINE; PROXYMETACAINE; STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LONG TERM CARE; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; THICKNESS; VISION;

AGED; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PSEUDOPHAKIA; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 0347530371     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1395-3907.2003.0146.x     Document Type: Article

References (34)

1. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ & Marshall J (2001): Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 108: 765-772.
2. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyar AB & Billson FA (1998): Exudative macular degeneration and triamcinolone. 18-month follow-up. Aust N Z J Ophthalmol 26: 277-281.
3. Danis RP, Bingaman DP, Yang Y & Ladd B (1996): Inhibition of preretinal and optic nervehead neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103: 2099-2104.
4. Danis RP, Ciulla TA, Pratt LM & Anliker W (2000): Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-250.
5. Flach AJ (1998): The incidence, pathogenesis, and treatment of cystoid macular oedema following cataract surgery. [Review.] Trans Am Ophthalmol Soc 96: 557-634.
6. Flach AJ, Dolan BJ & Irvine AR (1987): Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular oedema. Am J Ophthalmol 103: 479-486.
7. Flach AJ, Stegma RC, Graham J & Kruger LP (1990): Prophylaxis of aphakic cystoid macular oedema without corticosteroids: a paired-comparison, placebo-controlled, double-masked study. Ophthalmology 97: 1253-1258.
8. Gass JD, Anderson DR & Davis EB (1985): A clinical, fluorescein angiographic and electron microscopic correlation of cystoid macular oedema. Am J Ophthalmol 100: 82-86.
9. Ip MS & Kumar KS (2002): Intravitreal triamcinolone acetonide as treatment for macular oedema from central retinal vein occlusion. Arch Ophthalmol 120: 1217-1219.
10. Irvine AR (1976): Cystoid maculopathy. Surv Ophthalmol 21: 1-17.
11. Jampol LM (1985): Pharmacologic therapy of aphakic and pseudophakic cystoid macular oedema: 1985 update. Ophthalmology 92: 807-810.
12. Jonas JB, Hayler JK & Panda-Jonas S (2000): Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 84: 1064-1067.
13. Jonas JB, Kreissig I & Degenring RF (2002): Intravitreal triamcinolone acetonide as treatment of macular oedema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240: 782-783.
14. Jonas JB & Sófker A (2001): Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular oedema. Am J Ophthalmol 132: 425-427.
15. Kraff MC, Sanders DR, Jampol LM & Lieberman HL (1984): Effect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular oedema. Am J Ophthalmol 98: 166-170.
16. Levy JH & Pisacona AM (1987): Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. J Cataract Refract Surg 13: 548-550.
17. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E & Baumal C (2002): Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 109: 920-927.
18. Martidis A, Duker JS & Puliafito CA (2001): Intravitreal triamcinolone for refractory cystoid macular oedema secondary to bird-shot retinochoroidopathy. Arch Ophthalmol 119: 1380-1383.
19. Miami Study Group (1979): Cystoid macular oedema in aphakic and pseudophakic eyes. Am J Ophthalmol 88: 45-48.
20. Miyake K, Sugiyama S, Norimatsu I & Takayuki O (1980): Aqueous prostaglandins in persistent cystoid macular oedema secondary to vitreous incarceration: effects of pars plana vitrectomy. Jpn J Ophthalmol 24: 335-345.
21. Pendergast SD, Magherio RR, Williams GA & Cox MS (1999): Vitrectomy for chronic pseudophakic cystoid macular oedema. Am J Ophthalmol 128: 317-323.
22. Penfold PL, Gyory JF, Hunyor AB & Billson FA (1995): Exudative macular degeneration and triamcinolone. A pilot study. Aust N Z J Ophthalmol 23: 293-298.
23. Peyman GA, Canakis C, Livir-Rallatos C & Conway MD (2002): The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular oedema: a report of two cases. Am J Ophthalmol 133: 571-572.
24. Pfoff DS & Thom SR (1987): Preliminary report on the effect of hyperbaric oxygen on cystoid macular oedema. J Cataract Refract Surg 13: 136-140.
25. Solomon LD (1995): Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular oedema: Flurbiprofen-CME Study Group I. J Cataract Refract Surg 21: 73-81.
26. Spaide RF & Yannuzzi LA (1993): Cystoid macular oedema after cataract surgery. Sem Ophthalmol 8: 121-129.
27. Suckling RD & Maslin KF (1988): Pseudophakic cystoid macular oedema and its treatment with local corticosteroids. Aust N Z J Ophthalmol 16: 353-359.
28. Tchah H, Rosenberg M, Larson RS & Lindstrom RL (1989): Neodymium:YAG laser vitreolysis for treatment and prophylaxis of cystoid macular oedema. Aust N Z J Ophthalmol 17: 179-183.
29. Tolentino FI & Schepens CL (1965): Oedema of the posterior pole after cataract extraction: a biomicroscopic study. Arch Ophthalmol 74: 781-786.
30. Tripathi RC, Fekrat S, Tripathi BJ & Ernest JT (1991): A direct correlation of the resolution of pseudophakic cystoid macular oedema with acetazolamide therapy. Ann Ophthalmol 23: 127-129.
31. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT & de Juan E Jr (1992): Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110: 1155-1159.
32. Wright PL, Wilkinson CP, Balyeat HD, Popham J & Reinke M (1988): Angiographic cystoid macular oedema after posterior chamber lens implantation. Arch Ophthalmol 106: 740-744.
33. Yannuzzi LA (1984): A perspective on the treatment of aphakic cystoid macular oedema. Surv Ophthalmol 28: 540-553.
34. Young S, Larkin G, Branley M & Lightman S (2001): Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 29: 2-6.